Our Values

Building on its technological lead, CROSSJECT’s ambition is to become the world’s leading pharmaceutical company for self-administered emergency products.
In order to innovate, CROSSJECT has assembled a high-performance team of specialists from different industries, bringing together the know-how required at every stage of its development.
After 20 years of R&D, CROSSJECT now has a self-injection device that is protected until 2038.
The ZENEO® needle-free injection system will save lives in emergency situations.

CSR

Corporate Social Responsibility (CSR) refers to the voluntary commitment of companies to integrate social, environmental, and economic concerns into their operations. This approach enables committed companies to maximize their performance and sustainability while ensuring profitability.

CSR aims to ensure the well-being of employees by fostering respectful and motivating working conditions. Simultaneously, CSR helps optimize company expenses by reducing energy consumption and the use of raw materials, thereby also lowering the ecological footprint.

This initiative must also address the societal expectations of various stakeholders, such as future employees who are still students. Anticipating regulations is another key aspect of CSR. Embracing a CSR approach is a powerful lever to support CROSSJECT’s evolution. Adopting responsible and sustainable practices not only meets societal expectations but is also a critical success factor in the company’s growth.

“The recognition of our strong commitment and our daily mission to save lives motivates the entire CROSSJECT team in this CSR ambition.”
Xavière CASTANO
Co-Founder and CSR Director
“CSR is the foundation of a sustainable and viable economy, enabling the sharing of common sense and highlighting a unique concept that saves lives.”
Patrick ALEXANDRE
Chairman of the Executive Board

Responsible Care

In October 2019, CROSSJECT signed the Responsible Care® charter, a global chemical industry initiative, to formalize its commitment to corporate social responsibility.

Procurement and CSR:

much more than synergy!

"Suppliers are beginning to discuss innovations supporting CSR.
The dialogue must take place across the entire value chain."
Charley MICHAUX
Procurement Director

A procurement process based on three pillars: equality, fairness, and transparency in treatment.

A supplier panel primarily composed of French companies manufacturing in France.

Supplier proposals qualified through discrimination criteria, including a CSR rating.

Ethical charter

The ethical charter of our company embodies our commitment to conducting business with integrity, transparency, and responsibility. It serves as the foundation of our corporate culture, guiding the actions and decisions of our employees, partners, and stakeholders. Acting ethically, particularly by respecting the Universal Declaration of Human Rights, and adhering to all rules governing our activities, must be a goal for everyone and each of us individually.

This is a major objective for CROSSJECT, forming an integral part of each of our values, to continually enhance the trust everyone places in our company.

CROSSJECT has obtained the EthiFinance 2024 certificate

Silver Level

To reward its ESG performance in 2023

A measured commitment

The CSR policy of listed companies is evaluated annually by EthiFinance, a European agency specializing in ESG (Environmental, Social, and Governance) performance ratings. Aligning our strategy with the Gaïa framework (evaluation of 250 CSR criteria) is an asset for investors and public actors. This commitment demonstrates our maturity and continuous progress in the index, reflecting our mastery of the levers as an innovative pharmaceutical company. We follow a strict approach, yet one inspired by the reality of field experience, which sets progress goals while allowing significant autonomy to the actors. 

CROSSJECT is ranked in the TOP 5 of the “Health Equipment and Services” subsector.

A recognized commitment

France Chimie Responsible Care Award: On April 11, 2022, CROSSJECT received the special jury award at the “4th Chemistry Meeting” organized by France Chimie Auvergne-Rhône-Alpes.

Winner of the RSE Trophies for the Bourgogne-Franche-Comté region, in the category of Fair Business Practices – 2021 Edition.

Challenge Mobilité Bourgogne-Franche-Comté: Winner in the category of 50 to 249 employees in December 2024. Over 4,500 km traveled using sustainable mobility between September 16 and 20, 2024.